comparemela.com

Latest Breaking News On - Director ronda - Page 1 : comparemela.com

Stryker Co (NYSE:SYK) Position Lessened by Clifford Swan Investment Counsel LLC

Clifford Swan Investment Counsel LLC reduced its stake in shares of Stryker Co. (NYSE:SYK – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,203 shares of the medical technology company’s stock after selling 1,060 shares […]

Piper Sandler Increases Stryker (NYSE:SYK) Price Target to $380 00

Stryker (NYSE:SYK – Free Report) had its target price boosted by Piper Sandler from $375.00 to $380.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an overweight rating on the medical technology company’s stock. Several other research analysts also recently commented on the stock. Canaccord Genuity Group upgraded shares of […]

Stryker (NYSE:SYK) Price Target Increased to $405 00 by Analysts at Roth Mkm

Stryker (NYSE:SYK) Price Target Increased to $405 00 by Analysts at Roth Mkm
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stryker (NYSE:SYK) Price Target Raised to $351 00

Stryker (NYSE:SYK – Free Report) had its price target upped by UBS Group from $339.00 to $351.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a neutral rating on the medical technology company’s stock. A number of other analysts have also commented on the company. TD Cowen lifted their price […]

Wells Fargo & Company Boosts Stryker (NYSE:SYK) Price Target to $381 00

Stryker (NYSE:SYK – Free Report) had its target price lifted by Wells Fargo & Company from $364.00 to $381.00 in a research report sent to investors on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical technology company’s stock. A number of other brokerages have also weighed in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.